Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004060490 | SCV002715443 | uncertain significance | not specified | 2022-10-29 | criteria provided, single submitter | clinical testing | The p.C566Y variant (also known as c.1697G>A), located in coding exon 10 of the GALNT12 gene, results from a G to A substitution at nucleotide position 1697. The cysteine at codon 566 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |